Page last updated: 2024-08-17

9,10-dimethyl-1,2-benzanthracene and em 800

9,10-dimethyl-1,2-benzanthracene has been researched along with em 800 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bélanger, A; Labrie, C; Labrie, F; Luo, S; Sourla, A1
Labrie, C; Labrie, F; Luo, S; Stojanovic, M1
Bélanger, A; Candas, B; Labrie, C; Labrie, F; Luo, S1

Other Studies

3 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and em 800

ArticleYear
Combined effects of dehydroepiandrosterone and EM-800 on bone mass, serum lipids, and the development of dimethylbenz(A)anthracene-induced mammary carcinoma in the rat.
    Endocrinology, 1997, Volume: 138, Issue:10

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Alkaline Phosphatase; Animals; Benzopyrans; Bone Density; Calcium; Carcinogens; Cell Transformation, Neoplastic; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Estradiol; Estrogen Antagonists; Female; Genitalia, Female; Lipids; Luteinizing Hormone; Mammary Neoplasms, Experimental; Organ Size; Phosphorus; Prolactin; Propionates; Random Allocation; Rats; Rats, Sprague-Dawley

1997
Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats.
    International journal of cancer, 1997, Nov-14, Volume: 73, Issue:4

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Adrenal Glands; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Benzopyrans; Carcinogens; Cell Division; Drug Screening Assays, Antitumor; Estrogen Antagonists; Estrone; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Organ Size; Propionates; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Progesterone; Uterus; Vagina

1997
Prevention of development of dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat by the new nonsteroidal antiestrogen EM-800 (SCH57050).
    Breast cancer research and treatment, 1998, Volume: 49, Issue:1

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benzopyrans; Body Weight; Bone and Bones; Bone Density; Estrogen Antagonists; Female; Lipids; Mammary Neoplasms, Experimental; Organ Size; Ovary; Prodrugs; Propionates; Rats; Rats, Sprague-Dawley; Stereoisomerism; Uterus; Vagina

1998